Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $153.21M | $132.09M | $568.09M | $157.90M | $138.65M |
| Total Operating Revenue | $153.21M | $132.09M | $568.09M | $157.90M | $138.65M |
| Cost of Revenue | $47.54M | $41.32M | $179.93M | $49.12M | $44.42M |
| Gross Profit | $105.67M | $90.77M | $388.16M | $108.78M | $94.23M |
| Operating Expense | $86.95M | $81.90M | $331.87M | $87.06M | $82.98M |
| Selling and Admin Expenses | $82.74M | $78.33M | $314.03M | $82.76M | $78.66M |
| Research & Development | $3.17M | $2.47M | $12.11M | $3.01M | $2.92M |
| Depreciation & Amortization & Depletion | $1.04M | $1.11M | $5.73M | $1.30M | $1.40M |
| -Depreciation & Amortization | $1.04M | $1.11M | $5.73M | $1.30M | $1.40M |
| Operating Profit | $18.71M | $8.87M | $56.29M | $21.72M | $11.25M |
| Net Non-Operating Interest Income (Expense) | -$4.07M | -$4.33M | -$26.49M | -$5.31M | -$6.18M |
| Non-Operating Interest Expense | $4.07M | $4.33M | $26.49M | $5.31M | $6.18M |
| Other Income (Expense) | $664,000.00 | -$27,000.00 | -$4.10M | -$2.27M | -$404,000.00 |
| Special Income (Charges) | $415,000.00 | -$454,000.00 | -$2.64M | -$2.24M | -$325,000.00 |
| -Less:Restructuring and Mergern & Acquisition | -$415,000.00 | $454,000.00 | $2.24M | $2.24M | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | $0.00 | -$81,000.00 | $0.00 | $1,000.00 |
| Other Non-Operating Income (Expenses) | $249,000.00 | $427,000.00 | -$1.45M | -$37,000.00 | -$79,000.00 |
| Pretax Profit | $15.31M | $4.52M | $25.71M | $14.14M | $4.67M |
| Tax | -$20.90M | $571,000.00 | -$1.57M | -$3.18M | $664,000.00 |
| Net Profit | $36.21M | $3.95M | $27.27M | $17.32M | $4.01M |
| Profit from Continuing Operations | $36.21M | $3.95M | $27.27M | $17.32M | $4.01M |
| Minority Interests | $2.76M | $833,000.00 | $4.54M | $2.56M | $851,000.00 |
| Net Income to Parent Company | $33.44M | $3.11M | $22.73M | $14.76M | $3.16M |
| Net Income to Common Stockholders | $33.44M | $3.11M | $22.73M | $14.76M | $3.16M |
| Basic EPS | $0.49 | $0.05 | $0.34 | $0.22 | $0.05 |
| Diluted EPS | $0.47 | $0.04 | $0.33 | $0.21 | $0.05 |
| -Less:Impairment of Capital Assets | – | – | $0.00 | $0.00 | $0.00 |
| -Less:Other Special Charges | – | – | $326,000.00 | $0.00 | $326,000.00 |
| Net Income from Discontinuous Operations | – | – | $0.00 | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $673.35M | $650.54M | $683.56M | $683.56M | $701.59M |
| Total Current Assets | $257.53M | $249.81M | $272.84M | $272.84M | $280.90M |
| Cash and Cash Equivalents & Short-Term Investments | $29.46M | $35.85M | $51.24M | $51.24M | $42.16M |
| -Cash and Cash Equivalents | $29.46M | $35.85M | $51.24M | $51.24M | $42.16M |
| Receivables | $138.41M | $120.53M | $128.30M | $128.30M | $130.40M |
| -Accounts Receivable | $138.41M | $120.53M | $128.30M | $128.30M | $130.40M |
| Inventory | $79.81M | $83.19M | $82.24M | $82.24M | $96.27M |
| Other Current Assets | $9.86M | $10.26M | $11.07M | $11.07M | $12.06M |
| Total Non-Current Assets | $415.82M | $400.73M | $410.72M | $410.72M | $420.69M |
| Net PPE | $24.75M | $25.98M | $27.02M | $27.02M | $28.81M |
| -Gross PPE | $24.75M | $25.98M | $81.29M | $81.29M | $28.81M |
| Goodwill and Other Intangible Assets | $358.51M | $367.12M | $375.88M | $375.88M | $384.86M |
| -Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M |
| -Other Intangible Assets | $351.05M | $359.66M | $368.42M | $368.42M | $377.40M |
| Non-Current Deferred Assets | $29.05M | $5.52M | $5.52M | $5.52M | $4.75M |
| Other Non-Current Assets | $3.51M | $2.10M | $2.29M | $2.29M | $2.27M |
| Total Liabilities | $395.93M | $416.27M | $455.11M | $455.11M | $494.34M |
| Total Current Liabilities | $152.45M | $148.10M | $160.38M | $160.38M | $161.75M |
| Payables | $26.36M | $28.86M | $16.06M | $16.06M | $31.48M |
| -Accounts Payable | $20.20M | $24.05M | $10.93M | $10.93M | $26.65M |
| -Total Tax Payable | $6.16M | $4.81M | $5.14M | $5.14M | $4.83M |
| Current Accrued Expenses | $78.05M | $74.20M | $101.70M | $101.70M | $93.27M |
| Short-Term Debt and Capital Lease Obligation | $18.75M | $18.75M | $15.00M | $15.00M | $11.25M |
| -Current Debt | $18.75M | $18.75M | $15.00M | $15.00M | $11.25M |
| Other Current Liabilities | $22.43M | $20.09M | $21.06M | $21.06M | $19.09M |
| Total Non-Current Liabilities | $243.48M | $268.18M | $294.73M | $294.73M | $332.59M |
| Long Term Debt and Capital Lease Obligation | $229.70M | $253.33M | $278.95M | $278.95M | $311.33M |
| -Long Term Debt | $229.70M | $253.33M | $278.95M | $278.95M | $311.33M |
| Non-Current Deferred Liabilities | $568,000.00 | $568,000.00 | $433,000.00 | $433,000.00 | $786,000.00 |
| Other Non-Current Liabilities | $13.21M | $14.29M | $15.35M | $15.35M | $20.47M |
| Total Equity | $277.41M | $234.27M | $228.45M | $228.45M | $207.26M |
| Stockholders' Equity | $228.31M | $188.90M | $184.11M | $184.11M | $166.10M |
| Capital Stock | $84,000.00 | $84,000.00 | $83,000.00 | $83,000.00 | $83,000.00 |
| -Common Stock | $84,000.00 | $84,000.00 | $83,000.00 | $83,000.00 | $83,000.00 |
| Additional Paid-In Capital | $527.93M | $522.91M | $520.85M | $520.85M | $517.53M |
| Retained Earnings | -$298.38M | -$331.82M | -$334.93M | -$334.93M | -$349.68M |
| Gains/Losses Not Affecting Retained Earnings | -$1.33M | -$2.28M | -$1.90M | -$1.90M | -$1.84M |
| Minority Interests | $49.11M | $45.36M | $44.34M | $44.34M | $41.16M |
| -Accumulated Depreciation | – | – | -$54.26M | -$54.26M | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $19.87M | $8.93M | $74.67M | $37.97M | $30.10M |
| Net cash flow from continuing operations | $19.87M | $8.93M | $74.67M | $37.97M | $30.10M |
| Net Income from Continuing Operations | $36.21M | $3.95M | $27.27M | $17.32M | $4.01M |
| Gain/Loss from Continuing Operations | $54,000.00 | $54,000.00 | $47,000.00 | -$27,000.00 | $357,000.00 |
| Depreciation & Depletion & Amortization | $10.95M | $11.21M | $47.01M | $11.69M | $11.40M |
| Deferred Tax | -$22.29M | $135,000.00 | -$909,000.00 | -$1.13M | $135,000.00 |
| Other Non-Cash Items | $170,000.00 | $275,000.00 | $1.16M | $155,000.00 | $243,000.00 |
| Change in Working Capital | -$10.17M | -$10.18M | -$13.84M | $6.21M | $10.68M |
| -Change in Receivables | -$17.94M | $7.32M | -$916,000.00 | $1.89M | $1.82M |
| -Change in Inventory | $2.96M | -$2.65M | $8.57M | $12.97M | $291,000.00 |
| -Change in Payables and Accrued Expense | $3.82M | -$15.37M | -$19.81M | -$4.44M | $7.31M |
| -Change In Other Working Capital | $990,000.00 | $522,000.00 | -$1.68M | -$4.20M | $1.25M |
| Net cash flow from investing | -$2.46M | -$574,000.00 | -$3.25M | -$580,000.00 | -$473,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$2.46M | -$574,000.00 | -$3.25M | -$580,000.00 | -$473,000.00 |
| Net PPE Purchase and Sale | -$960,000.00 | -$574,000.00 | -$2.56M | -$580,000.00 | -$473,000.00 |
| Financing Cash Flow | -$23.43M | -$23.14M | -$62.14M | -$28.45M | -$19.98M |
| Net Cash Flow from Continuing Financing Activities | -$23.43M | -$23.14M | -$62.14M | -$28.45M | -$19.98M |
| Net Issuance Payments Of Debt | -$23.75M | -$22.00M | -$42.91M | -$28.75M | -$19.16M |
| Net Common Stock Issuance | $853,000.00 | $120,000.00 | $2.07M | $511,000.00 | $96,000.00 |
| Net Other Financing Charges | -$535,000.00 | -$1.26M | -$21.30M | -$208,000.00 | -$913,000.00 |
| Ending Cash Balance | $29.46M | $35.85M | $51.24M | $51.24M | $42.16M |
| Net Change in Cash | -$6.02M | -$14.78M | $9.29M | $8.94M | $9.65M |
| Beginning Cash Balance | $35.85M | $51.24M | $41.58M | $42.16M | $32.91M |
| Effect of Exchange Rate Changes | -$370,000.00 | -$608,000.00 | $371,000.00 | $133,000.00 | -$394,000.00 |
| Free Cash Flow | $18.91M | $8.36M | $72.11M | $37.39M | $29.63M |
| Cash Flow from Discontinued Operating Activities | – | – | $0.00 | – | – |
| Net Business Purchase and Sale | – | – | -$686,000.00 | $0.00 | $0.00 |
| Net Investment Purchase and Sale | – | – | $0.00 | $0.00 | $0.00 |
No comments yet — be the first to weigh in on BVS.